| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.410230112 |
| P698 | PubMed publication ID | 3345068 |
| P50 | author | Andrew John Lees | Q4757729 |
| P2093 | author name string | Stern GM | |
| Poewe WH | |||
| P2860 | cites work | Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease | Q28326772 |
| Paralysis agitans of early onset with marked diurnal fluctuation of symptoms | Q34699963 | ||
| Dystonic foot response of Parkinsonism | Q42271509 | ||
| Hereditary dystonia-parkinsonism syndrome of juvenile onset | Q45176330 | ||
| P433 | issue | 1 | |
| P921 | main subject | pharmacology | Q128406 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 73-78 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Dystonia in Parkinson's disease: clinical and pharmacological features | |
| P478 | volume | 23 |
| Q64865050 | Q64865050 |
| Q36847246 | Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease |
| Q30868245 | Bromocriptine for levodopa-induced motor complications in Parkinson's disease |
| Q24243591 | Bromocriptine versus levodopa in early Parkinson's disease |
| Q33790640 | Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism |
| Q64860977 | Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale |
| Q34452721 | Clinical spectrum of levodopa-induced complications |
| Q33630384 | Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon? |
| Q67217660 | Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia |
| Q34512173 | Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? |
| Q45759333 | Difference of foot posture in two cases of exercise-induced foot dystonia |
| Q36902632 | Drug treatment of Parkinson's disease |
| Q34744720 | Dystonia and dyskinesia |
| Q34328686 | Dystonia and parkinsonism |
| Q34585274 | Dystonia in Parkinson's disease |
| Q35466200 | Dystonia in multiple system atrophy |
| Q92583689 | Dystonic Pseudo Foot Drop |
| Q60050856 | Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester |
| Q34458647 | Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias |
| Q55712409 | Index Finger Pointing (Likely a Subtle Form of Hand Dystonia): Prevalence Across Movement Disorders. |
| Q28325153 | Levodopa-associated hemifacial dystonia |
| Q89414347 | Levodopa-induced dyskinesia: clinical features, incidence, and risk factors |
| Q35129374 | Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management. |
| Q35592786 | Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's disease |
| Q38051280 | Management of pain in Parkinson's disease |
| Q55279095 | Motor Complications of Dopaminergic Medications in Parkinson's Disease. |
| Q48529183 | Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey |
| Q45098438 | Neuroradiological covariates of drug-induced parkinsonism and tardive dyskinesia in schizophrenia |
| Q29616302 | Parkinson's disease |
| Q33821336 | Pharmacotherapy for advanced Parkinson's disease |
| Q92583915 | Postural, Bone, and Joint Disorders in Parkinson's Disease |
| Q36473516 | Psychiatric symptoms associated with oculogyric crisis: a review of literature for the characterization of antipsychotic-induced episodes |
| Q64759887 | Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders |
| Q64806325 | Severe off-period facial dystonia in Parkinson's disease |
| Q28648007 | Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia |
| Q36166588 | Striatal deformities of the hand and foot in Parkinson's disease |
| Q33863502 | Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia |
| Q69916337 | Subcutaneous apomorphine in Parkinson's disease |
| Q37809795 | The clinical spectrum of levodopa-induced motor complications |
| Q34533843 | The clinical symptoms of Parkinson's disease |
| Q22250951 | The differential diagnosis of Parkinson's disease |
| Q33597960 | The genetics of idiopathic torsion dystonia |
| Q33688757 | Treating and preventing levodopa-induced dyskinesias: current and future strategies |
| Q42277562 | “Off” painful dystonia in Parkinson's disease treated with botulinum toxin |
Search more.